The integrin alpha IIb beta 3 was initially believed to be expressed o
nly in cells from the megakaryocytic lineage, such as platelets or HEL
cells. In this study, we report for the first time that human prostat
e carcinoma PC-3 and DU-145 cells express alpha IIb beta 3. Reverse tr
anscription-PCR from HEL (positive control), PC-3, and DU-145 cells am
plified a predicted alpha II beta fragment that hybridized to the full
-length alpha II beta cDNA probe. DNA sequencing of the PCR fragments
revealed 100% sequence homology to the corresponding extracellular dom
ain of platelet alpha II beta but minimal sequence homology to integri
ns alpha v or alpha 5. An RNase protection assay was used to confirm t
he results from reverse transcription-PCR. An antisense riboprobe to a
lpha IIb mRNA hybridized to total RNA from HEL, PC-3, and DU-145 cells
, suggesting that alpha IIb mRNA is transcribed in these tumor cells.
In situ hybridization on surgical specimens from human prostate tumor
tissue stained positive,vith an antisense riboprobe to alpha IIb mRNA,
The expression of alpha IIb beta 3 protein in PC-3 and DU-145 cells w
as demonstrated by Western and dot blotting and flow cytometry with mo
noclonal antibodies (mAbs) to alpha IIb (MAB 1990), beta 3, and alpha
IIb beta 3 (AP-2). A protein kinase C activator, phorbol 12-myristate
13-acetate, increased the adhesion of PC-3 cells to PAC-1, a mAb speci
fic to the high-affinity state of alpha IIb beta 3, by more than 80-fo
ld. The invasion of DU-145 cells through a reconstituted basement memb
rane was blocked 40-50% by mAbs AP-2 or PAC-1. These data collectively
suggest that: (a) prostate tumor cells express alpha IIb beta 3; (b)
surface expression of alpha IIb beta 3 integrin is regulated by protei
n kinase C; and (c) mAbs to this receptor inhibit invasion of prostate
cancer cells through a reconstituted basement membrane.